Clinical Trial Results:
Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell carcinoma
Summary
|
|
EudraCT number |
2007-006611-23 |
Trial protocol |
EE LT CZ NL PT GB FI SE DE GR IT |
Global completion date |
03 Feb 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
31 Jan 2016
|
First version publication date |
31 Jan 2016
|
Other versions |
|
Summary report(s) |
CTg Receipt MO21609 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.